Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.

Identifieur interne : 000407 ( Main/Exploration ); précédent : 000406; suivant : 000408

Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.

Auteurs : Heidi L. Pecoraro [États-Unis] ; Justin S. Lee ; Jenna Achenbach ; Stuart Nelson ; Gabriele A. Landolt

Source :

RBID : pubmed:23543928

Descripteurs français

English descriptors

Abstract

We conducted a cross-sectional convenience sampling study of dogs racing in the 2010 Iditarod to determine the seroprevalence of canine influenza virus (CIV) in the sled dog population. Questionnaires were completed detailing medical and CIV vaccination history, kennel size and location, travel history, and social interactions for each team. A total of 399 dogs were tested for CIV antibodies by hemagglutination inhibition assay. None of these, including 39 samples from dogs reported as CIV vaccinated, were seropositive for CIV antibodies. All of the vaccinated dogs were also negative on virus microneutralization assay. Risk factors for CIV seropositivity could not be determined due to a lack of positive samples. This is the first published study investigating the prevalence of CIV in sled dogs and additional studies are warranted to assess CIV infection among racing sled dogs and to evaluate the ecology of CIV and the vaccine efficacy in this population of dogs.

PubMed: 23543928


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.</title>
<author>
<name sortKey="Pecoraro, Heidi L" sort="Pecoraro, Heidi L" uniqKey="Pecoraro H" first="Heidi L" last="Pecoraro">Heidi L. Pecoraro</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, CO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, CO</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Justin S" sort="Lee, Justin S" uniqKey="Lee J" first="Justin S" last="Lee">Justin S. Lee</name>
</author>
<author>
<name sortKey="Achenbach, Jenna" sort="Achenbach, Jenna" uniqKey="Achenbach J" first="Jenna" last="Achenbach">Jenna Achenbach</name>
</author>
<author>
<name sortKey="Nelson, Stuart" sort="Nelson, Stuart" uniqKey="Nelson S" first="Stuart" last="Nelson">Stuart Nelson</name>
</author>
<author>
<name sortKey="Landolt, Gabriele A" sort="Landolt, Gabriele A" uniqKey="Landolt G" first="Gabriele A" last="Landolt">Gabriele A. Landolt</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23543928</idno>
<idno type="pmid">23543928</idno>
<idno type="wicri:Area/Main/Corpus">000371</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000371</idno>
<idno type="wicri:Area/Main/Curation">000371</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000371</idno>
<idno type="wicri:Area/Main/Exploration">000371</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.</title>
<author>
<name sortKey="Pecoraro, Heidi L" sort="Pecoraro, Heidi L" uniqKey="Pecoraro H" first="Heidi L" last="Pecoraro">Heidi L. Pecoraro</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, CO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, CO</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Justin S" sort="Lee, Justin S" uniqKey="Lee J" first="Justin S" last="Lee">Justin S. Lee</name>
</author>
<author>
<name sortKey="Achenbach, Jenna" sort="Achenbach, Jenna" uniqKey="Achenbach J" first="Jenna" last="Achenbach">Jenna Achenbach</name>
</author>
<author>
<name sortKey="Nelson, Stuart" sort="Nelson, Stuart" uniqKey="Nelson S" first="Stuart" last="Nelson">Stuart Nelson</name>
</author>
<author>
<name sortKey="Landolt, Gabriele A" sort="Landolt, Gabriele A" uniqKey="Landolt G" first="Gabriele A" last="Landolt">Gabriele A. Landolt</name>
</author>
</analytic>
<series>
<title level="j">The Canadian veterinary journal = La revue veterinaire canadienne</title>
<idno type="ISSN">0008-5286</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Viral (blood)</term>
<term>Canada (epidemiology)</term>
<term>Cross-Sectional Studies</term>
<term>Dogs</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests (veterinary)</term>
<term>Influenza A Virus, H3N8 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Male</term>
<term>Orthomyxoviridae Infections (epidemiology)</term>
<term>Orthomyxoviridae Infections (veterinary)</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps antiviraux (sang)</term>
<term>Canada (épidémiologie)</term>
<term>Chiens</term>
<term>Femelle</term>
<term>Infections à Orthomyxoviridae (médecine vétérinaire)</term>
<term>Infections à Orthomyxoviridae (épidémiologie)</term>
<term>Mâle</term>
<term>Sous-type H3N8 du virus de la grippe A (immunologie)</term>
<term>Tests d'inhibition de l'hémagglutination (médecine vétérinaire)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Études séroépidémiologiques</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Sous-type H3N8 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A Virus, H3N8 Subtype</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr">
<term>Infections à Orthomyxoviridae</term>
<term>Tests d'inhibition de l'hémagglutination</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en">
<term>Hemagglutination Inhibition Tests</term>
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Canada</term>
<term>Infections à Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cross-Sectional Studies</term>
<term>Dogs</term>
<term>Female</term>
<term>Male</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Chiens</term>
<term>Femelle</term>
<term>Mâle</term>
<term>Études séroépidémiologiques</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We conducted a cross-sectional convenience sampling study of dogs racing in the 2010 Iditarod to determine the seroprevalence of canine influenza virus (CIV) in the sled dog population. Questionnaires were completed detailing medical and CIV vaccination history, kennel size and location, travel history, and social interactions for each team. A total of 399 dogs were tested for CIV antibodies by hemagglutination inhibition assay. None of these, including 39 samples from dogs reported as CIV vaccinated, were seropositive for CIV antibodies. All of the vaccinated dogs were also negative on virus microneutralization assay. Risk factors for CIV seropositivity could not be determined due to a lack of positive samples. This is the first published study investigating the prevalence of CIV in sled dogs and additional studies are warranted to assess CIV infection among racing sled dogs and to evaluate the ecology of CIV and the vaccine efficacy in this population of dogs.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23543928</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>05</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0008-5286</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>53</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2012</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Canadian veterinary journal = La revue veterinaire canadienne</Title>
<ISOAbbreviation>Can. Vet. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.</ArticleTitle>
<Pagination>
<MedlinePgn>1091-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We conducted a cross-sectional convenience sampling study of dogs racing in the 2010 Iditarod to determine the seroprevalence of canine influenza virus (CIV) in the sled dog population. Questionnaires were completed detailing medical and CIV vaccination history, kennel size and location, travel history, and social interactions for each team. A total of 399 dogs were tested for CIV antibodies by hemagglutination inhibition assay. None of these, including 39 samples from dogs reported as CIV vaccinated, were seropositive for CIV antibodies. All of the vaccinated dogs were also negative on virus microneutralization assay. Risk factors for CIV seropositivity could not be determined due to a lack of positive samples. This is the first published study investigating the prevalence of CIV in sled dogs and additional studies are warranted to assess CIV infection among racing sled dogs and to evaluate the ecology of CIV and the vaccine efficacy in this population of dogs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pecoraro</LastName>
<ForeName>Heidi L</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Justin S</ForeName>
<Initials>JS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Achenbach</LastName>
<ForeName>Jenna</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>Stuart</ForeName>
<Initials>S</Initials>
<Suffix>Jr</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Landolt</LastName>
<ForeName>Gabriele A</ForeName>
<Initials>GA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Can Vet J</MedlineTA>
<NlmUniqueID>0004653</NlmUniqueID>
<ISSNLinking>0008-5286</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
<QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053123" MajorTopicYN="N">Influenza A Virus, H3N8 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherAbstract Type="Publisher" Language="fre">
<AbstractText>
<b>Séroprévalence du virus de la grippe canine (H3N8) chez les chiens de traîneau de la course Iditarod.</b>
Nous avons réalisé une étude par sondage des chiens de la course Iditarod 2010 afin de déterminer la séroprévalence du virus de la grippe canine (VGC) dans la population de chiens de traîneau. Les questionnaires remplis fournissaient des détails complets sur les antécédents médicaux et l’historique de vaccination contre le VGC, la taille du chenil et l’emplacement, l’historique des déplacements et les interactions sociales entre chaque équipe. Un total de 399 chiens a été testé pour les anticorps du VGC par un test d’inhibition de l’hémagglutination. Aucun de ces tests, incluant les 39 échantillons provenant de chiens déclarés comme étant vaccinés contre le VGC, étaient séropositifs pour les anticorps de la VGC. Tous les chiens vaccinés ont aussi eu des résultats négatifs au test de microneutralisation. Les facteurs de risque pour la séropositivité au VGC n’ont pas pu être déterminés en raison d’une absence d’échantillons positifs. Il s’agit de la première étude publiée étudiant la prévalence du VGC chez les chiens de traîneaux et des études additionnelles sont nécessaires pour évaluer l’infection par le VGC chez les chiens de traîneau de course et déterminer l’écologie du VGC et l’efficacité du vaccin chez cette population de chiens.(Traduit par Isabelle Vallières).</AbstractText>
</OtherAbstract>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>5</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23543928</ArticleId>
<ArticleId IdType="pmc">PMC3447312</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Am Vet Med Assoc. 2001 Mar 15;218(6):900-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11294315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Vet Med Assoc. 2011 Mar 15;238(6):726-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21401429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Zoonoses. 1976 Jun;3(1):61-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">977232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1982 Apr;15(4):660-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7040463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phys Med Biol. 1997 Nov;42(11):2027-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9394395</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1999 Apr;37(4):937-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10074505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Oct 21;310(5747):482-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16186182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2006 Jul;20(4):339-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16289758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2007 Apr;7(4):257-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17376383</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Vet Med Assoc. 2007 May 15;230(10):1486-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17504039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Rec. 2007 Jul 28;161(4):142-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17660470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2007 Oct 19;3(10):1470-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17953482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2008 Mar;14(3):461-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18325262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can Vet J. 2008 Aug;49(8):800-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18978976</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2008 Nov;22(8):1152-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18616997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Ther. 2009 Fall;10(3):103-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20037964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Vet Med Assoc. 2010 Jul 1;237(1):71-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20590497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vet Intern Med. 2010 Nov-Dec;24(6):1524-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21155162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1968 Oct 26;220(5165):395-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4879332</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Colorado</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Achenbach, Jenna" sort="Achenbach, Jenna" uniqKey="Achenbach J" first="Jenna" last="Achenbach">Jenna Achenbach</name>
<name sortKey="Landolt, Gabriele A" sort="Landolt, Gabriele A" uniqKey="Landolt G" first="Gabriele A" last="Landolt">Gabriele A. Landolt</name>
<name sortKey="Lee, Justin S" sort="Lee, Justin S" uniqKey="Lee J" first="Justin S" last="Lee">Justin S. Lee</name>
<name sortKey="Nelson, Stuart" sort="Nelson, Stuart" uniqKey="Nelson S" first="Stuart" last="Nelson">Stuart Nelson</name>
</noCountry>
<country name="États-Unis">
<region name="Colorado">
<name sortKey="Pecoraro, Heidi L" sort="Pecoraro, Heidi L" uniqKey="Pecoraro H" first="Heidi L" last="Pecoraro">Heidi L. Pecoraro</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000407 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000407 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23543928
   |texte=   Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23543928" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020